ZYNE
Zynerba Pharmaceuticals Inc
North American company
Healthcare
Drug Manufacturers - Specialty & Generic
/
Bid
-
Ask
-
Last Traded
-
Chg
-
-
XNAS
-
Updated: -
Research
News & analysis
Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery.
NASDAQ:ZYNE
US98986X1090
USD
Loading Comparison
Latest ZYNE News